vs

Side-by-side financial comparison of Charles River Laboratories (CRL) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.

SERVICE CORP INTERNATIONAL is the larger business by last-quarter revenue ($1.1B vs $994.2M, roughly 1.1× Charles River Laboratories). SERVICE CORP INTERNATIONAL runs the higher net margin — 14.3% vs -27.8%, a 42.2% gap on every dollar of revenue. On growth, SERVICE CORP INTERNATIONAL posted the faster year-over-year revenue change (1.7% vs -0.8%). SERVICE CORP INTERNATIONAL produced more free cash flow last quarter ($87.2M vs $58.6M). Over the past eight quarters, SERVICE CORP INTERNATIONAL's revenue compounded faster (3.1% CAGR vs -0.9%).

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.

CRL vs SCI — Head-to-Head

Bigger by revenue
SCI
SCI
1.1× larger
SCI
$1.1B
$994.2M
CRL
Growing faster (revenue YoY)
SCI
SCI
+2.5% gap
SCI
1.7%
-0.8%
CRL
Higher net margin
SCI
SCI
42.2% more per $
SCI
14.3%
-27.8%
CRL
More free cash flow
SCI
SCI
$28.6M more FCF
SCI
$87.2M
$58.6M
CRL
Faster 2-yr revenue CAGR
SCI
SCI
Annualised
SCI
3.1%
-0.9%
CRL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRL
CRL
SCI
SCI
Revenue
$994.2M
$1.1B
Net Profit
$-276.6M
$159.4M
Gross Margin
28.0%
Operating Margin
-28.5%
24.8%
Net Margin
-27.8%
14.3%
Revenue YoY
-0.8%
1.7%
Net Profit YoY
-28.9%
5.3%
EPS (diluted)
$-5.57
$1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRL
CRL
SCI
SCI
Q4 25
$994.2M
$1.1B
Q3 25
$1.0B
$1.1B
Q2 25
$1.0B
$1.1B
Q1 25
$984.2M
$1.1B
Q4 24
$1.0B
$1.1B
Q3 24
$1.0B
$1.0B
Q2 24
$1.0B
$1.0B
Q1 24
$1.0B
$1.0B
Net Profit
CRL
CRL
SCI
SCI
Q4 25
$-276.6M
$159.4M
Q3 25
$54.4M
$117.5M
Q2 25
$52.3M
$122.9M
Q1 25
$25.5M
$142.9M
Q4 24
$-214.5M
$151.4M
Q3 24
$69.7M
$117.8M
Q2 24
$94.1M
$118.2M
Q1 24
$73.0M
$131.3M
Gross Margin
CRL
CRL
SCI
SCI
Q4 25
28.0%
Q3 25
25.1%
Q2 25
25.5%
Q1 25
27.1%
Q4 24
28.0%
Q3 24
34.6%
24.9%
Q2 24
34.5%
24.9%
Q1 24
34.1%
26.2%
Operating Margin
CRL
CRL
SCI
SCI
Q4 25
-28.5%
24.8%
Q3 25
13.3%
21.4%
Q2 25
9.7%
21.1%
Q1 25
7.6%
23.4%
Q4 24
-16.7%
24.0%
Q3 24
11.6%
20.9%
Q2 24
14.8%
21.4%
Q1 24
12.5%
22.2%
Net Margin
CRL
CRL
SCI
SCI
Q4 25
-27.8%
14.3%
Q3 25
5.4%
11.1%
Q2 25
5.1%
11.5%
Q1 25
2.6%
13.3%
Q4 24
-21.4%
13.8%
Q3 24
6.9%
11.6%
Q2 24
9.2%
11.4%
Q1 24
7.2%
12.6%
EPS (diluted)
CRL
CRL
SCI
SCI
Q4 25
$-5.57
$1.13
Q3 25
$1.10
$0.83
Q2 25
$1.06
$0.86
Q1 25
$0.50
$0.98
Q4 24
$-4.17
$1.02
Q3 24
$1.33
$0.81
Q2 24
$1.74
$0.81
Q1 24
$1.30
$0.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRL
CRL
SCI
SCI
Cash + ST InvestmentsLiquidity on hand
$213.8M
$243.6M
Total DebtLower is stronger
$2.1B
$5.1B
Stockholders' EquityBook value
$3.2B
$1.6B
Total Assets
$7.1B
$18.7B
Debt / EquityLower = less leverage
0.68×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRL
CRL
SCI
SCI
Q4 25
$213.8M
$243.6M
Q3 25
$207.1M
$241.3M
Q2 25
$182.8M
$255.4M
Q1 25
$229.4M
$227.2M
Q4 24
$194.6M
$218.8M
Q3 24
$210.2M
$185.4M
Q2 24
$179.2M
$184.4M
Q1 24
$327.0M
$205.6M
Total Debt
CRL
CRL
SCI
SCI
Q4 25
$2.1B
$5.1B
Q3 25
$2.2B
$5.0B
Q2 25
$2.3B
$5.0B
Q1 25
$2.5B
$4.7B
Q4 24
$2.2B
$4.8B
Q3 24
$2.3B
$4.7B
Q2 24
$2.4B
$4.7B
Q1 24
$2.7B
$4.6B
Stockholders' Equity
CRL
CRL
SCI
SCI
Q4 25
$3.2B
$1.6B
Q3 25
$3.4B
$1.6B
Q2 25
$3.4B
$1.6B
Q1 25
$3.2B
$1.7B
Q4 24
$3.5B
$1.7B
Q3 24
$3.8B
$1.6B
Q2 24
$3.7B
$1.5B
Q1 24
$3.6B
$1.6B
Total Assets
CRL
CRL
SCI
SCI
Q4 25
$7.1B
$18.7B
Q3 25
$7.5B
$18.4B
Q2 25
$7.6B
$18.0B
Q1 25
$7.6B
$17.3B
Q4 24
$7.5B
$17.4B
Q3 24
$8.0B
$17.4B
Q2 24
$7.9B
$16.8B
Q1 24
$8.2B
$16.7B
Debt / Equity
CRL
CRL
SCI
SCI
Q4 25
0.68×
3.10×
Q3 25
0.64×
3.17×
Q2 25
0.70×
3.19×
Q1 25
0.79×
2.87×
Q4 24
0.65×
2.83×
Q3 24
0.62×
2.92×
Q2 24
0.65×
3.05×
Q1 24
0.73×
2.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRL
CRL
SCI
SCI
Operating Cash FlowLast quarter
$147.5M
$212.9M
Free Cash FlowOCF − Capex
$58.6M
$87.2M
FCF MarginFCF / Revenue
5.9%
7.8%
Capex IntensityCapex / Revenue
8.9%
11.3%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$518.5M
$554.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRL
CRL
SCI
SCI
Q4 25
$147.5M
$212.9M
Q3 25
$213.8M
$252.3M
Q2 25
$204.6M
$166.4M
Q1 25
$171.7M
$311.1M
Q4 24
$159.4M
$264.1M
Q3 24
$251.8M
$263.8M
Q2 24
$193.5M
$196.9M
Q1 24
$129.9M
$220.1M
Free Cash Flow
CRL
CRL
SCI
SCI
Q4 25
$58.6M
$87.2M
Q3 25
$178.2M
$150.7M
Q2 25
$169.3M
$83.4M
Q1 25
$112.4M
$233.0M
Q4 24
$83.7M
$151.8M
Q3 24
$213.1M
$162.8M
Q2 24
$154.0M
$100.8M
Q1 24
$50.7M
$140.3M
FCF Margin
CRL
CRL
SCI
SCI
Q4 25
5.9%
7.8%
Q3 25
17.7%
14.2%
Q2 25
16.4%
7.8%
Q1 25
11.4%
21.7%
Q4 24
8.4%
13.9%
Q3 24
21.1%
16.1%
Q2 24
15.0%
9.7%
Q1 24
5.0%
13.4%
Capex Intensity
CRL
CRL
SCI
SCI
Q4 25
8.9%
11.3%
Q3 25
3.5%
9.6%
Q2 25
3.4%
7.8%
Q1 25
6.0%
7.3%
Q4 24
7.5%
10.3%
Q3 24
3.8%
10.0%
Q2 24
3.8%
9.3%
Q1 24
7.8%
7.6%
Cash Conversion
CRL
CRL
SCI
SCI
Q4 25
1.34×
Q3 25
3.93×
2.15×
Q2 25
3.91×
1.35×
Q1 25
6.74×
2.18×
Q4 24
1.75×
Q3 24
3.61×
2.24×
Q2 24
2.06×
1.67×
Q1 24
1.78×
1.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRL
CRL

Discovery And Safety Assessment Segment$591.6M60%
Manufacturing Support Segment$196.4M20%
Transferred At Point In Time$108.0M11%
Transferred Over Time$98.3M10%

SCI
SCI

Cemetery$510.9M46%
Funeral Matured Preneed Revenue$196.5M18%
Cemetery Recognized Preneed Merchandise And Service Revenue$107.4M10%
Cemetery Atneed Revenue$104.9M9%
CA$56.4M5%
Funeral Other Revenue$54.6M5%
Cemetery Other Revenue$40.2M4%
Nonfuneral Home Revenue$28.1M3%
Non Funeral Home Preneed Sales Revenue$22.0M2%

Related Comparisons